QNRXQuoin Pharmaceuticals, Ltd.vs its industry peers
A metric-by-metric comparison of Quoin Pharmaceuticals, Ltd. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QNRXThis | $296M#4 | — | 75.3x#4 | — | — | -75.6%#9 | — | -401.8%#6 | — | — | -61.6%#4 | — |
| PRQR | $144M#5 | — | — | — | — | — | — | — | — | — | -47.1%#2 | — |
| PRTCY | — | — | — | — | 475.3%#3 | 181.4%#1 | -3154.0%#8 | 12.9%#1 | — | — | — | — |
| PTCHF | — | — | — | — | 475.3%#3 | 181.4%#1 | -3154.0%#8 | 12.9%#1 | — | — | — | — |
| PVCT | — | — | — | — | -45.5%#9 | 15.6%#7 | -1575.3%#5 | — | — | — | — | — |
| QNTM | $27#8 | — | — | — | — | — | — | — | — | — | -79.0%#7 | — |
| QUCY | $61M#7 | — | 3.0x#2 | 113.8x#3 | -39.9%#7 | 24.9%#3 | -3005.0%#7 | -79.6%#4 | -203.8%#1 | — | -50.9%#3 | — |
| QURE | $1.5B#3 | — | 10.1x#3 | 93.6x#2 | -40.6%#8 | 16.9%#6 | -1151.4%#4 | -133.3%#5 | -263.3%#2 | — | -30.1%#1 | — |
| RADX | $3.2B#2 | — | — | 868.2x#4 | 1114.3%#1 | 20.0%#4 | -1050.6%#2 | — | — | — | -83.2%#8 | — |
| RANI | $99M#6 | — | 2.5x#1 | 60.8x#1 | 58.9%#5 | 1.1%#8 | -2346.0%#6 | -75.6%#3 | — | — | -74.5%#6 | — |
| RDHL | $23.2B#1 | — | — | 2883.9x#5 | 23.2%#6 | -134.6%#10 | -181.7%#1 | — | — | — | -64.4%#5 | — |
| RDPTF | — | — | — | — | 1114.3%#1 | 20.0%#4 | -1050.6%#2 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice